Penciclovir

This classification denotes a purine antagonist and antiviral agent with the molecular formula C10H15N5O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 359HUE8FJC, chemically known as 6h-purin-6-one, 2-amino-1,9-dihydro-9-(4-hydroxy-3-(hydroxymethyl)butyl)- & human interferon-.gamma. but generally known as penciclovir, which bears US NIH Compound Identifier 4725. European Medicines Agency schedules Penciclovir in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09661MIG. The term PENCICLOVIR is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 4, No. 3 1990, List 30). World Health Organization schedules penciclovir in its Anatomical Therapeutic Chemical (ATC) Classification. PENCICLOVIR is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule penciclovir under HS 29335995 and SITC 51576. As of Q4 2014, PENCICLOVIR remains the US FDA Preferred Term for this commodity. Penciclovir bears US NLM identifiers UMLS ID C0164815 and NCI Concept Code C66337. SMILES: C1=NC2=C(N1CCC(CO)CO)NC(=NC2=O)N.